Acute behavior disorder and hypopotasemia in a 49-year-old male;Varón de 49 años con trastorno agudo de la conducta e hipopotasemia

Medicina Clinica

Volumn 126, Issue 3, 2006, Pages 110-115

  Manzanares, José María ^a   De Juan, Carmen ^b   Castillo, Mireia ^b  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; CORTICOTROPIN; GADOLINIUM;

ADULT; BEHAVIOR DISORDER; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTRAST ENHANCEMENT; CORTICOTROPIN RELEASE; CUSHING SYNDROME; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; HUMAN; HYPOKALEMIA; LABORATORY TEST; MALE; PATHOLOGICAL ANATOMY; THORAX RADIOGRAPHY;

EID: 33644526960     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13083882     Document Type: Conference Paper

References (23)

1. Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocrine Reviews. 1998;19:647-72.
2. Burt VL, Whelton P, Roccella E. Prevalence of hypertension in the U.S. adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-91. Hypertension. 1995;25:305-13.
3. Howlett TA, Drury PL, Perry L, Doniach I, Rees LH, Besser GM. Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features inectopic and pitiutary ACTH production. Clin Endocrinol. 1986;24:699-713.
4. Miller WL, Tyrrell JB. The adrenal cortex. En: Felig P, Baxter JD, Frohman LA, editors. Endocrinology and metabolism 3rd ed. New York: McGraw-Hill; 1995. p. 555-709.
5. Orth DN, Kovacs WJ. The adrnal cortex. En: Wilson D, Foster DW, Kronenberg HM, Larsen PR, editors. Williams textbook of endocrinology. 9th ed. WB Philadelphia: Saunders Company; 2002. p. 517-664.
6. Frohman LA. Diseases of the anterior pituitary. En: Felig P, Baxter JD, Frohman LA, editors. Endocrinology and metabolism. 3rd. New York: McGraw-Hill; 1995. p. 289-383.
7. Ilias I, Torpy DJ, Pacak K, Mullen M, Wesley RA, Nieman LK. Cushing's syndrome due to ectopic corticotropin secretion: Twenty Years' Experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005;90:4955-62.
8. Molina R, Agustí C, Filella X, Jo I, Joseph J, Giménez N, et al. Study of a new tumor marker, CYFRA 21-1, in malignant and nonmalignant diseases. Tumour Biol. 1994;15:318-25.
9. Molina R, Filella X, Auge JM, Fuentes R, Bover I, Rifa J, et al. Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors. Tumour Biol. 2003;24:209-18.
10. Grote TH, Macon WR, Davis B, Greco KA, Johnson D. Atypical carcinoid of the lung. A distinct clinicopathological entity. Chest. 1988;93:370-5.
11. Jex RK, VanHeesden JA, Carpenter K, Grant CS. Ectopic ACTH syndrome: Diagnostic and therapeutic aspects. Am J Surg. 1985;149:276-80.
12. Strollo DC, Rosado de Christenson ML. Tumours of the thymus. J Thorac Imaging. 1999;14:152-71.
13. Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, et al. Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol. 2003;149:543-8.
14. 111In-DTPA labelled octreotide scintigraphy. J Endocrinol Invest. 1997;20:327-30.
15. Orlefors H, Sundin A, Garske U, Juhlin C, Oberg K, Skogseid B, et al. Whole-body 11C-5-hydroxytryptophan positron emission tomography as a universal technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab. 2005;90:3392-400.
16. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. Pathology and genetics of tumours of the lung, pleura, thymus and heart. World Health Organization classification of tumours. Lyon: IARC press; 2004. p. 188-95.
17. Moran CA, Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol. 2000;114:100-10.
18. Soga J, Yakuwa Y, Osaka M. Evaluation of 342 cases of mediastinal/thymic carcinoids collected from literature: a comparative study between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg. 1999;5:285-92.
19. De Perrot M, Spiliopoulos A, Fischer S, Totsch M, Keshavjee S. Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing's syndrome. Ann Thorac Surg. 2002;73:675-81.
20. Oliveira AM, Tazelaar HD, Myers JL, Erickson LA, Lloyd RV. Thyroid Transcription Factor-1 distinguishes metastatic pulmonary from well-differentaited neuroendocrine tumors of other sites. Am J Surg Oathol. 2001;25:815-9.
21. Du EZ, Goldstraw P, Zacharias J, Tiffet O, Craig PJ, Nicholson AG, et al. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1 positive carcinoids are predominantly in peripheral location. Hum Pathol. 2004;35:825-31.
22. Saqi A, Alexis D, Remotti F, Bhagat G. Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids. Am J Clin Pathol. 2005;123:394-404.
23. Aniszewski JP, Young Jr WF, Thompson GB, Grant CS, Van Heerden JA. Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg. 2001;25:934-40.